Gougelet Angélique, Colnot Sabine
Inserm U1016, Institut Cochin, 24, rue du Faubourg Saint-Jacques, 75014 Paris, France; CNRS UMR 8104, 75014 Paris, France - université Paris Descartes, Sorbonne Paris Cité, 75006 Paris, France.
Med Sci (Paris). 2013 Oct;29(10):861-7. doi: 10.1051/medsci/20132910013. Epub 2013 Oct 18.
microRNA are small non coding RNA, which negatively regulate the expression of their targets. Due to their various targets, miRNAs play a key role in number of physiological processes and in oncogenesis. The identification of specific miRNA signatures in various types of tumours, including hepatocellular carcinoma (HCC), highlights the dual role of miRNA, both oncogenes and tumour suppressors. Here, we review the current knowledge concerning the deregulation of miRNA expression in liver disease. All studies focusing on miRNAs argue for their possible use as diagnostic, prognostic and therapeutic markers. Here, we preferentially discuss the promising therapeutic strategies based on miRNAs that have been tested in HCC.
微小RNA是一类小的非编码RNA,它们对其靶标的表达起负向调节作用。由于其具有多种靶标,微小RNA在许多生理过程以及肿瘤发生过程中发挥着关键作用。在包括肝细胞癌(HCC)在内的各种肿瘤类型中鉴定出特定的微小RNA特征,凸显了微小RNA作为癌基因和肿瘤抑制因子的双重作用。在此,我们综述了有关肝脏疾病中微小RNA表达失调的现有知识。所有关注微小RNA的研究都认为它们有可能用作诊断、预后和治疗标志物。在此,我们优先讨论基于已在肝细胞癌中进行测试的微小RNA的有前景的治疗策略。